Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Vasopressin antagonist VPA-985: summary of clinical data presented at ASN

Nov. 9, 1999

Antifibrotic agent pirfenidone slows the progression of glomerulosclerosis

Nov. 8, 1999

News from ASN: PDGF tyrosine kinase is a target for intervention in renal diseases

Nov. 8, 1999

Agents for urinary incontinence, pollakiuria in early development at Fujisawa

Nov. 4, 1999

U Penn researchers identify new target for treatment of erectile dysfunction

Nov. 2, 1999

Proof-of-concept trial begins for Vivus's oral PE compounds

Oct. 21, 1999

AnorMed initiates phase III clinical trials in U.S. for Lambda

Oct. 20, 1999

FDA approves Rochester Medical's FemSoft Insert for female stress urinary incontinence

Oct. 5, 1999

New muscarinic antagonists developed at Roche

Oct. 4, 1999

Alpha1A/1L-adrenoceptor agonists disclosed for urinary incontinence, etc.

Oct. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...